These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19404829)

  • 1. Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.
    Metzger J; Luppa PB; Good DM; Mischak H
    Crit Rev Clin Lab Sci; 2009; 46(3):129-52. PubMed ID: 19404829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
    Zürbig P; Schiffer E; Mischak H
    Methods Mol Biol; 2009; 564():105-21. PubMed ID: 19544019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.
    Stalmach A; Albalat A; Mullen W; Mischak H
    Electrophoresis; 2013 Jun; 34(11):1452-64. PubMed ID: 23512263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary electrophoresis interfaced with a mass spectrometer (CE-MS): technical considerations and applicability for biomarker studies in animals.
    Albalat A; Husi H; Siwy J; Nally JE; McLauglin M; Eckersall PD; Mullen W
    Curr Protein Pept Sci; 2014 Feb; 15(1):23-35. PubMed ID: 24555889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods in capillary electrophoresis coupled to mass spectrometry for the identification of clinical proteomic/peptidomic biomarkers in biofluids.
    Stalmach A; Husi H; Mosbahi K; Albalat A; Mullen W; Mischak H
    Methods Mol Biol; 2015; 1243():187-205. PubMed ID: 25384747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining capillary electrophoresis with mass spectrometry for applications in proteomics.
    Simpson DC; Smith RD
    Electrophoresis; 2005 Apr; 26(7-8):1291-305. PubMed ID: 15765477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
    Fliser D; Wittke S; Mischak H
    Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in capillary electrophoresis-based high-sensitivity proteomics].
    Yang Y; Tian R
    Se Pu; 2020 Oct; 38(10):1125-1132. PubMed ID: 34213109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
    Stepczynska A; Schanstra JP; Mischak H
    Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Schiffer E; Mischak H; Novak J
    Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of metabolomics and proteomics based on capillary electrophoresis-mass spectrometry].
    Wang F; Wang S; Cong H; Yu B
    Se Pu; 2020 Sep; 38(9):1013-1021. PubMed ID: 34213267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation.
    Zürbig P; Renfrow MB; Schiffer E; Novak J; Walden M; Wittke S; Just I; Pelzing M; Neusüss C; Theodorescu D; Root KE; Ross MM; Mischak H
    Electrophoresis; 2006 Jun; 27(11):2111-25. PubMed ID: 16645980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary proteomics based on capillary electrophoresis coupled to mass spectrometry in kidney disease.
    Albalat A; Franke J; Gonzalez J; Mischak H; Zürbig P
    Methods Mol Biol; 2013; 919():203-13. PubMed ID: 22976103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment.
    Dakna M; He Z; Yu WC; Mischak H; Kolch W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1250-8. PubMed ID: 19010091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capillary electrophoresis-mass spectrometry and its application to proteomic analysis].
    Liang Y; Zhang L; Zhang Y
    Se Pu; 2020 Oct; 38(10):1117-1124. PubMed ID: 34213108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments.
    Metzger J; Schanstra JP; Mischak H
    Anal Bioanal Chem; 2009 Mar; 393(5):1431-42. PubMed ID: 18704377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends of capillary electrophoresis-mass spectrometry in proteomics research.
    Gomes FP; Yates JR
    Mass Spectrom Rev; 2019 Nov; 38(6):445-460. PubMed ID: 31407381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.